News

15.03.2021

Exemption from Testing by Detection of Neutralizing Antibodies

10.03.2021

cPass detect neutralizing antibodies against Mutation B.1.1.7

10.11.2020

GenScript Biotech and medac GmbH Enter into Exclusive Agreement to Distribute World's First SARS-CoV-2 Neutralizing Antibody Detection Kit in Germany and Austria

…more …more …more
Exemption from Testing by Detection of Neutralizing Antibodies

Austria: Currently, the 4th amendment to the 4th COVID-19 protective measures regulation is in effect. Key changes...

cPass detect neutralizing antibodies against Mutation B.1.1.7

The highly infectious coronavirus variant that was first detected in the U.K is now rapidly spreading. Neutralizing...

GenScript Biotech and medac GmbH Enter into Exclusive Agreement to Distribute World's First SARS-CoV-2 Neutralizing Antibody Detection Kit in Germany and Austria

The cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit can be performed within an hour in standard laboratories,...

News archive